Teva reports fourth quarter and full year 2021 financial results

Tel aviv, israel--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva) today reported results for the year and the quarter ended december 31, 2021. q4 2021 and fy 2021 highlights:   q4 2021 fy 2021   revenues   $4.1 billion $15.9 billion gaap diluted eps   $(0.14) $0.38 non-gaap diluted eps   $0.77 $2.58 cash flow generated from operating activities   $456 million $798 million free cash flow   $716 million $2,196 million 2022 business outlook: revenues are expected to be $
TEVA Ratings Summary
TEVA Quant Ranking